关注
gerald raverot
gerald raverot
Hospices Civils de Lyon, Lyon university
在 chu-lyon.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
J Trouillas, P Roy, N Sturm, E Dantony, C Cortet-Rudelli, G Viennet, ...
Acta neuropathologica 126, 123-135, 2013
4812013
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
G Raverot, P Burman, A McCormack, A Heaney, S Petersenn, V Popovic, ...
European journal of endocrinology 178 (1), G1-G24, 2018
4712018
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
MR Gadelha, MD Bronstein, T Brue, M Coculescu, M Fleseriu, ...
The lancet Diabetes & endocrinology 2 (11), 875-884, 2014
3952014
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ...
The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010
3952010
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families
AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ...
The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007
3642007
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
SL Asa, O Casar-Borota, P Chanson, E Delgrange, P Earls, S Ezzat, ...
Endocrine-related cancer 24 (4), C5-C8, 2017
3032017
Ketoconazole in Cushing's disease: is it worth a try?
F Castinetti, L Guignat, P Giraud, M Muller, P Kamenicky, D Drui, P Caron, ...
The Journal of Clinical Endocrinology & Metabolism 99 (5), 1623-1630, 2014
2952014
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
A Wierinckx, C Auger, P Devauchelle, A Reynaud, P Chevallier, M Jan, ...
Endocrine-related cancer 14 (3), 887-900, 2007
2512007
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
A McCormack, OM Dekkers, S Petersenn, V Popovic, J Trouillas, ...
European Journal of Endocrinology 178 (3), 265-276, 2018
2502018
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience
G Raverot, N Sturm, F de Fraipont, M Muller, S Salenave, P Caron, ...
The Journal of Clinical Endocrinology & Metabolism 95 (10), 4592-4599, 2010
2482010
Management of clinically non-functioning pituitary adenoma
P Chanson, G Raverot, F Castinetti, C Cortet-Rudelli, F Galland, ...
Annales d'endocrinologie 76 (3), 239-247, 2015
2182015
Sox3 is required for gonadal function, but not sex determination, in males and females
J Weiss, JJ Meeks, L Hurley, G Raverot, A Frassetto, JL Jameson
Molecular and cellular biology, 2003
2132003
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up
G Raverot, A Wierinckx, E Dantony, C Auger, G Chapas, L Villeneuve, ...
The Journal of Clinical Endocrinology & Metabolism 95 (4), 1708-1716, 2010
1882010
Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal: Personal experience and review of the literature
M Messerer, G Raverot, S Kassis, J Dubourg, V Lapras, J Trouillas, ...
Neurosurgical focus 30 (4), E11, 2011
1852011
Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1
D D'Angelo, D Palmieri, P Mussnich, M Roche, A Wierinckx, G Raverot, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), E1128-E1138, 2012
1742012
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
G Raverot, F Castinetti, E Jouanneau, I Morange, D Figarella‐Branger, ...
Clinical Endocrinology 76 (6), 769-775, 2012
1722012
Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography
M Jacob, G Raverot, E Jouanneau, F Borson-Chazot, G Perrin, ...
American journal of ophthalmology 147 (1), 64-70. e2, 2009
1722009
Sox3 expression in undifferentiated spermatogonia is required for the progression of spermatogenesis
G Raverot, J Weiss, SY Park, L Hurley, JL Jameson
Developmental biology 283 (1), 215-225, 2005
1712005
Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome
M Pugeat, N Nader, K Hogeveen, G Raverot, H Déchaud, C Grenot
Molecular and cellular endocrinology 316 (1), 53-59, 2010
1692010
Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women
P Cousin, L Calemard-Michel, H Lejeune, G Raverot, N Yessaad, ...
The Journal of Clinical Endocrinology & Metabolism 89 (2), 917-924, 2004
1692004
系统目前无法执行此操作,请稍后再试。
文章 1–20